We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
At the ECM 23 (European Crystallographic Meeting), Incoatec GmbH from Hamburg, Germany, an innovative manufacturer of X-ray optics, and Bruker AXS Inc., a leading global provider of advanced X-ray solutions for life and advanced materials sciences, launch their novel IuS X-ray microsource, the brightest sealed-tube X-ray generator ever.
AdvaMed President and CEO, Stephen J. Ubl, issued the following statement regarding the "Health Information Technology (HIT) Promotion Act of 2006'' (H.R. 4157).
A U.S. Senate committee has boosted the biotechnology industry's hope that legislation will soon again allow many venture-backed companies to win research grants set aside for small businesses.
A maker of power wheelchairs is "disappointed" in the lack of specifics provided by the Centers for Medicare & Medicaid Services (CMS) on quality standards for suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS).
Sen. Pat Roberts (R-Kan.) Aug. 3 introduced a bill that would repeal provisions in the Deficit Reduction Act (DRA) to transfer ownership of oxygen equipment to Medicare beneficiaries after 36 months of use.
The device industry, which feared a Centers for Medicare & Medicaid Services (CMS) proposal to cut reimbursement rates under Medicare's inpatient prospective payment system (IPPS), can breathe a sigh of relief.
St. Jude Medical, Inc. recognized the significance of new published guidelines for the diagnosis and treatment of heart valve disease, developed by the American College of Cardiology (ACC) and the American Heart Association (AHA).
Sicel Technologies raised $12 million from existing and new investors to bring to market wireless, implantable sensors that promise to fine-tune radiation treatment.
Fourteen years since the launch of the national research and development program in 1982, Korea still has a long way to go in achieving its ambitions of becoming a biotechnological world power.